Evidence map›Paper›PMID 41541878›Full record

ArticleFrontiers in stroke2025

Comparison of admitting neutrophil/lymphocyte ratio with baseline NIH stroke scale score in discriminating poor 30-day stroke outcome among Nigerian Africans.

Oladotun V Olalusi, Joseph Yaria, Akintomiwa Makanjuola, Rufus Akinyemi, Mayowa Owolabi, Adesola Ogunniyi

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in stroke, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Oladotun V OlalusiDepartment of Neurology, University College Hospital, Ibadan, Nigeria.
Joseph YariaDepartment of Neurology, University College Hospital, Ibadan, Nigeria.
Akintomiwa MakanjuolaDepartment of Neurology, University College Hospital, Ibadan, Nigeria.
Rufus AkinyemiDepartment of Neurology, University College Hospital, Ibadan, Nigeria.
Mayowa OwolabiDepartment of Neurology, University College Hospital, Ibadan, Nigeria.
Adesola OgunniyiDepartment of Neurology, University College Hospital, Ibadan, Nigeria.

Funding

H3Africa Administrative Coordinating Centre: Enabling and Supporting Genomics and Health Research Capacity Building in AfricaU24HG009780 · NHGRI · UNIVERSITY OF CAPE TOWN · PI SKELTON, MICHELLE · 2017 to 2022
$4.8M
Stroke Investigative Research & Educational Network (SIREN)U54HG007479 · NHGRI · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI OVBIAGELE, BRUCE, OWOLABI, MAYOWA OJO · 2013 to 2017
$4.2M
CNV And Stroke (CaNVAS)R01NS114045 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI COLE, JOHN W. · 2020 to 2024
$2.6M
African Rigorous Innovative Stroke Epidemiological Surveillance (ARISES)R01NS115944 · NINDS · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI OVBIAGELE, BRUCE, OWOLABI, MAYOWA OJO · 2020 to 2025
$2.2M
Systematic Investigation of Blacks with Stroke - Genomics (SIBS-Genomics) StudyR01NS107900 · NINDS · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI OVBIAGELE, BRUCE, OWOLABI, MAYOWA OJO · 2018 to 2021
$1.8M
Training Africans to Lead and Execute Neurological Trials & Studies (TALENTS)D43TW012030 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OVBIAGELE, BRUCE · 2021 to 2025
$1.2M
Growing Data-science Research in Africa to Stimulate Progress (GRASP)UE5HL172183 · NHLBI · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI FATUMO, SEGUN, OVBIAGELE, BRUCE · 2023 to 2025
$568k
Sub-Saharan Africa Conference on Stroke (SSACS) ConferenceR13NS115395 · NINDS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI OVBIAGELE, BRUCE · 2020 to 2020
$50k
FIC NIH HHS D43 TW012030NHGRI NIH HHS U24 HG009780NHGRI NIH HHS U54 HG007479NHLBI NIH HHS UE5 HL172183NINDS NIH HHS R01 NS107900NINDS NIH HHS R01 NS114045NINDS NIH HHS R01 NS115944NINDS NIH HHS R13 NS115395
6 · The paper itself

Abstract

Aim: The National Institutes of Health Stroke Scale (NIHSS) score is an established marker of stroke severity. Its use is time-consuming and requires formal training for optimal results. In contrast, the neutrophil-lymphocyte ratio (NLR), known to be independently associated with stroke outcome, can be readily calculated from routine peripheral blood counts with minimal training. We hypothesized that the NLR may perform similarly to the NIHSS score, in discriminating persons with poor 30-day stroke outcome, in a low-resource setting. Methods: We followed up 106 participants with clinico-radiologic diagnosis of first-ever acute ischemic stroke (AIS). Patients with clinico-laboratory features of fever, aspiration pneumonia, sepsis, or infection were excluded at baseline. The NLR was obtained at admission while the functional outcome was assessed using the modified Rankin scale (mRS) score at day 30. Receiver operating characteristics (ROC) curves and Cox proportional hazards were used to determine the discriminatory ability of the NLR compared with the NIHSS score in identifying patients with poor 30-day stroke outcome (mRS > 3). The respective areas under the curves (AUC) and HRs (95%CI) were documented. Results: The median interquartile range (IQR) NLR of the study population was 2.87 (3.0). Patients in the higher tertiles of NLR had higher mean standard deviation 30-day mRS scores of 4.9 (1.2) compared to the middle 3.3 (1.2) and lower tertiles 2.3 (1.2) ( Conclusion: The NLR alone performed similarly to the NIHSS score and may help identify patients with adverse 30-day AIS outcome in low-resource settings.

Indexed as

30-day functional outcomeacute ischemic stroke (AIS)Indigenous West Africansischemic stroke mortalitymodified Rankins scale (mRS) scoreneutrophil-lymphocyte ratio (NLR)Nigerian AfricansNIH Stroke Scale (NIHSS) score

Identifiers

PMID41541878
PMCPMC12802611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.